Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Illumina Ventures

Illumina Ventures

Illumina Ventures is a venture capital firm in California focused on early-stage companies developing applications of genomics. It invests in therapeutics, life science tools, and clinical diagnostics.

Illumina Ventures is a corporate venture capital company in California that aims to improve human health by unlocking the power of the genome. Founded 2016 in Foster City, California, United States by Nicholas J. Naclerio, this venture capital firm invests in early stage companies. Its portfolio companies include Stilla Technologies, Ribometrix, Cradle Genomics, Encoded Therapeutics, Inc., DNA Script, LunaDNA, Kallyope, and SQZ Biotech. As of February 2020, Illumina Ventures has made 24 investments. Their most recent investment was on Feb 11, 2020, when Stilla Technologies raised €20M. Illumina Ventures has had two exits, the most notable of which include Human Longevity and Twist Bioscience. The company has raised 2 funds, their latest being Fund I. This fund was announced on Oct 16, 2017 and raised a total of $230M. The company focuses on applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness.

Timeline

2016
Founded

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Conor Hale
September 20, 2021
FierceBiotech
The proceeds will be used to support genomics-focused, early-stage startups looking to build new clinical diagnostics and life science research tools.
FinSMEs
September 20, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Rebus Biosystems
November 19, 2020
www.prnewswire.com:443
/PRNewswire/ -- Rebus Biosystems, Inc., a life science technology company building innovative tools to enable spatial omics without compromise, today announced...
Golden logo
By using this site, you agree to our Terms & Conditions.